Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants
Cell Proliferation · 2023-12 · 56 (12)
DOI: 10.1111/cpr.13494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 04.05.2023. Verfasst von Xuejiao Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource…. Hauptthemen laut MEDLINE: Antioxidants, Glycyrrhetinic Acid. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science and Technology Innovation Program of Shanghai Municipal Education Commission, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute liver injury (ALI) is a severe liver disease that is characterized by sudden and massive hepatocyte necrosis and deterioration of liver functions. Oxidative stress is increasingly recognized as a key factor in the induction and progression of ALI. Scavenging excessive reactive oxygen species (ROS) with antioxidants has become a promising therapeutic option, but intrinsically hepatocyte‐targeting antioxidants with excellent bioavailability and biocompatibility are yet to be developed. Herein, self‐assembling nanoparticles (NPs) composed of amphiphilic polymers are introduced to encapsulate organic Selenium compound L‐Se‐methylselenocysteine (SeMC) and form SeMC NPs, which protect the viabilities and functions of cultured hepatocytes in drug‐ or chemical‐induced acute hepatotoxicity models via efficient ROS removal. After further functionalization with the hepatocyte‐targeting ligand glycyrrhetinic acid (GA), the resultant GA‐SeMC NPs exhibit enhanced hepatocyte uptake and liver accumulation. In mouse models of ALI induced by acetaminophen (APAP) or carbon tetrachloride (CCl 4 ), treatment with GA‐SeMC NPs significantly decrease the levels of hepatic lipid peroxidation, tissue vacuolization and serum liver transaminases, while prominently increase that of endogenous antioxidant enzymes. Our study therefore presents a liver‐targeting drug delivery strategy for the prevention and treatment of hepatic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of Rare E…
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- He'nan Xibaikang Health Industry Co., Ltd, Jiyuan, China.
- Department of Neurology, Xuhui District Central Hospital, Shanghai, China.
ORCID-Profile: Yanfeng Zhou, Nan Chen
Förderung
- Major Science and Technology Innovation Program of Shanghai Municipal Education Commission
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Sailing Program
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Yuan, X., Zhou, Y., Sun, J., Wang, S., Hu, X., Li, J., Huang, J., & Chen, N. (2023). Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants. Cell Proliferation, 56(12). https://doi.org/10.1111/cpr.13494
Vancouver
Yuan X, Zhou Y, Sun J, Wang S, Hu X, Li J, et al. Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants. Cell Proliferation. 2023;56(12). doi:10.1111/cpr.13494
BibTeX
@article{Yuan2023,
author = {Yuan, Xuejiao and Zhou, Yanfeng and Sun, Jinli and Wang, Shanshan and Hu, Xingjie and Li, Jiyu and Huang, Jing and Chen, Nan},
title = {Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {12},
doi = {10.1111/cpr.13494}
}
EUVIMED